Mukesh Sajjanraj Bhandari Bhandari
About Mukesh Sajjanraj Bhandari Bhandari
Data last updated:
Mukesh Sajjanraj Bhandari Bhandari is a Director at Sri Guru Enterprises Pharma Private Limited (since 2022). The company operates in Pharma. Sri Guru Enterprises Pharma Private Limited reported revenue of ₹9.73 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sri Guru Enterprises Pharma Private Limited U51100TN2020PTC134500 | Director | 19 Mar 2022 | 2020 | ₹9.73 Cr (FY 2025) | Active |
Board colleagues of Mukesh Sajjanraj Bhandari Bhandari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Mehta | 09541189 | Sri Guru Enterprises Pharma Private Limited | Director |
| Jitendra Kothari | 09541167 | Sri Guru Enterprises Pharma Private Limited | Director |
| Ranjeet Kumar Kothari | 09541175 | Sri Guru Enterprises Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mukesh Sajjanraj Bhandari Bhandari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mukesh Sajjanraj Bhandari Bhandari
Mukesh Sajjanraj Bhandari Bhandari currently holds 1 directorship: Sri Guru Enterprises Pharma Private Limited (Director, since 19 Mar 2022, revenue ₹9.73 Cr (FY 2025)).
Mukesh Sajjanraj Bhandari Bhandari was first appointed on 19 Mar 2022 as Director at Sri Guru Enterprises Pharma Private Limited.
The current boards of Mukesh Sajjanraj Bhandari Bhandari's companies include Amit Mehta (Sri Guru Enterprises Pharma Private Limited), Jitendra Kothari (Sri Guru Enterprises Pharma Private Limited), Ranjeet Kumar Kothari (Sri Guru Enterprises Pharma Private Limited).